Using Real-World Data to Support Claim Expansion of the Cobas SARS-CoV-2 Test in Asymptomatic Testing: Data from the National Football League Occupational Surveillance Program

Based on data collected during this occupational testing protocol, our study provides strong evidence supporting real-world performance of this test in an asymptomatic population. These findings, complemented by data from an existing clinical study, provided the totality-of-evidence that supported the US Food and Drug Administration clearance for the expanded claim of the candidate test for the qualitative detection of SARS-CoV-2 in the asymptomatic population.

Authors

Institutions

Publication Details

Journal
Infectious Diseases and Therapy
Published
2026-03-15
DOI
https://doi.org/10.1007/s40121-026-01325-4
Primary Topic
SARS-CoV-2 detection and testing
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Using Real-World Data to Support Claim Expansion of the Cobas SARS-CoV-2 Test in Asymptomatic Testing: Data from the National Football League Occupational Surveillance Program

Ákos Somoskövi, Daniel A. Jarem, Erin B. Wasserman, Patrick Volkir et al.
Infectious Diseases and Therapy
SARS-CoV-2 detection and testing
article

Using Real-World Data to Support Claim Expansion of the Cobas SARS-CoV-2 Test in Asymptomatic Testing: Data from the National Football League Occupational Surveillance Program

Ákos Somoskövi, Daniel A. Jarem, Erin B. Wasserman, Patrick Volkir, Baiyu Yang, Christina Mack, Elodie Baumfeld Andre
article en

Abstract

Based on data collected during this occupational testing protocol, our study provides strong evidence supporting real-world performance of this test in an asymptomatic population. These findings, complemented by data from an existing clinical study, provided the totality-of-evidence that supported the US Food and Drug Administration clearance for the expanded claim of the candidate test for the qualitative detection of SARS-CoV-2 in the asymptomatic population.

Infectious Diseases and Therapy
Applied Materials (United States) (US), IQVIA (United Kingdom) (GB), IQVIA (United States) (US), Materials Systems (United States) (US), IQ Solutions (US)
National Football League Players Association
Good health and well-being
Openalex Percentile: Top 22%
SARS-CoV-2 detection and testing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.